Symbiosis II LLC (CLNN) reports multiple open‑market sales, incl. 67,991 shares

Rhea-AI Filing Summary

Symbiosis II LLC reported multiple open-market sales of Common Stock under Rule 144. The filing lists repeated dispositions between 01/28/2026 and 04/21/2026, including large blocks such as 67,991 shares on 03/31/2026 and 61,345 shares on 04/21/2026. The transactions were reported as cash open-market sales.

Key Figures

Largest single-date sale: 67,991 shares Notable single-date sale: 61,345 shares Example sale proceeds: $332,103.67 +2 more

5 metrics

Largest single-date sale 67,991 shares 03/31/2026

Notable single-date sale 61,345 shares 04/21/2026

Example sale proceeds $332,103.67 Proceeds for 67,991 shares on 03/31/2026

Example sale proceeds $376,718.05 Proceeds for 61,345 shares on 04/21/2026

Form type Form 144 Rule 144 notice of proposed sale

Key Terms

Rule 144, open-market sales, Form 144

3 terms

Rule 144 regulatory

"reported multiple open-market sales under Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

open-market sales market

"transactions labeled as Open Market Purchase / Cash"

Form 144 regulatory

"Filer Information and Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 555 California St Ste 1800 San Francisco CA 94104	56916	335804	11778307	04/28/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/30/2024	Open Market Purchase	Issuer			297066	09/30/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/28/2026	8717	42789.36
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/29/2026	3810	15843.2
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/29/2026	11474	50113.36
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/30/2026	5686	23493.07
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	02/02/2026	2050	8262.02
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	02/02/2026	1750	7102.19
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	02/03/2026	5559	22818.28
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/24/2026	5492	31722.97
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/25/2026	7098	39045.14
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/26/2026	5319	28705.91
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/27/2026	17470	82908.17
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/30/2026	15536	79283.66
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/31/2026	67991	332103.67
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/01/2026	4278	21254.31
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/02/2026	24925	119855.2
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/15/2026	6374	41300.6
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/16/2026	7748	49555.2
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/17/2026	25040	161097.44
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/20/2026	4318	26423.1
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/21/2026	61345	376718.05

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CLNN Form 144 filing show?

The filing reports Symbiosis II LLC sold shares in open-market transactions under Rule 144. It lists multiple sale dates from 01/28/2026 through 04/21/2026 with individual share counts and cash proceeds for each trade.

How many shares did Symbiosis II LLC sell on its largest reported date?

The largest single-date sale listed is 67,991 shares on 03/31/2026. The entry shows the share count and associated cash proceeds for that date as reported in the filing.

Were the sales in the CLNN Form 144 open-market or private placements?

The filing indicates these were open-market sales executed for cash. Each row in the excerpt labels the transactions as open-market purchases/sales with cash consideration.

Does the Form 144 state who received the sale proceeds?

The excerpt identifies the transactions as cash open-market sales by Symbiosis II LLC. It does not assign proceeds to another party or the issuer in the provided excerpt.

What date range do the reported transactions cover in the CLNN filing?

The reported transactions span from 01/28/2026 through 04/21/2026, with multiple discrete sales recorded on specific dates throughout that period.